Lionel Tarassenko | |
---|---|
Born | |
Nationality | British |
Alma mater | University of Oxford |
Spouse | Dr Anne Tarassenko |
Children | 3 children, 3 step-children |
Awards |
|
Scientific career | |
Fields | Biomedical Engineering, Signal Processing, Machine Learning, Digital Health |
Institutions | University of Oxford |
Lionel Tarassenko, CBE , FREng , FMedSci (born 17 April 1957) is a British engineer and academic, who is a leading expert in the application of signal processing and machine learning to healthcare. Tarassenko is President of Reuben College, Oxford.
He was previously Head of Department of Engineering Science (Dean of Engineering) at the University of Oxford, succeeded by Ronald A. Roy. [5] Towards the end of his time as Dean, the Department rose to number 1 in the Times Higher Education World University Rankings. [6]
Tarassenko was elected Professor of Electrical Engineering at the University of Oxford in 1997 [7] and was a Professorial Fellow of St John's College, Oxford, from 1997 to 2019. [8] In 2019 he was invited by the Vice-Chancellor Louise Richardson to oversee the development of Reuben College, the University's 39th college. [5] [9] He is also a Pro-Vice Chancellor [10] and the Chair of the Management Committee of the Maison Française d’Oxford. [11]
Tarassenko is the author of over 280 journal papers, 200 conference papers, 3 books and over 30 granted patents. [12] He has supervised 65 doctoral students. He has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012. [13] He was the R&D Director and Chair of the Strategic Advisory Board of Sensyne Health, an AIM-listed company from 2018 to 2022. [14] He is a director of the University’s wholly owned Technology Transfer company, Oxford University Innovation. [15] He was the editor-in-chief of the 2018 Topol Review of NHS Technology and its impact on the workforce. [16]
Tarassenko was the driving force behind the creation of the Institute of Biomedical Engineering (IBME) at the University of Oxford, which he directed from its opening in April, 2008 to October, 2012. He established an £8m Centre of Excellence in Medical Engineering within the IBME, [17] and led the Technology & Digital Health theme in the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre from its inception in 2007 until 2022. [18] Under his leadership, the IBME grew from 110 to 220 academic researchers and it was awarded a Queen’s Anniversary Prize for Higher Education in 2015 for “new collaborations between engineering and medicine delivering benefit to patients”. [19]
Tarassenko completed his BA in Engineering Science in 1978 at Keble College, University of Oxford. Later he obtained his DPhil in 1985, also at the University of Oxford for his work on the early identification of brain haemorrhages in pre-term infants.
Together with Professor Alan Murray of University of Edinburgh, Tarassenko is the inventor of the pulse-stream technique for analogue implementation of massively parallel neural networks. [20] He gradually moved away from designing neural network hardware to developing new machine learning algorithms and applying them to problems as diverse as the automated re-heating of food and drinks in a microwave oven (implemented in the Sharp LogiCook oven) and the analysis of sleep disorders. This body of work was recognised in 1996 by the award of the IEE Mather Premium for innovation using neural networks. [1]
Tarassenko then went on to develop methods for learning how to characterise normality in safety-critical systems. With his research team, he designed the QUICK system, which was at the core of Rolls-Royce’s engine health monitoring strategy in the 1990s and the early 2000s. [21] [22] As a result, he and his Rolls-Royce collaborators were awarded the Chairman’s Team Award for Technical Innovation in 2001 and the Sir Henry Royce High Value Patent Award in 2008.
When he became the first Director of the Oxford Institute of Biomedical Engineering in 2008, Tarassenko focused his research on patient monitoring, both in and out of hospital. His work has had a major impact on the identification of deterioration in acute care and on the management of long-term conditions. He has been a pioneer in developing early warning systems for acutely ill patients. The machine-learning system (Visensia) which he designed for patient monitoring in critical care was the first such system to gain FDA approval (in 2008). [23]
In the last decade Tarassenko has led the engineering development of several digital health products including: (a) GDm-Health, a digital therapeutic for the management of gestational diabetes; [24] (b) SEND, a system for monitoring in-hospital patient vital signs and identifying deterioration early; [25] [26] (c) EDGE-COPD, a digital therapeutic for the self-monitoring and self-management of chronic obstructive pulmonary disease; and (d) Support-HF, a system for heart failure management in the community.
Tarassenko has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012. [27]
Tarassenko was elected to a Fellowship of the Institute of Electrical Engineers in 1996, when he was also awarded the IEE Mather Premium for his work on neural networks, to a Fellowship of the Royal Academy of Engineering in 2000, [1] [28] and to a Fellowship of the Academy of Medical Sciences in 2013. He received a British Computer Society Medal in 1996 for his work on neural network analysis of sleep disorders. His research on jet engine health monitoring was awarded the Rolls-Royce Chairman's Award for Technical Innovation in 2001 and the Sir Henry Royce High Value Patent Award in 2008. His work on mobile phones for healthcare was awarded the E-health 2005 Innovation Award for “best device to empower patients”. He received the 2006 Silver Medal of the Royal Academy of Engineering for his contribution to British engineering leading to market exploitation and he won the Institute of Engineering & Technology IT Award, also in 2006. In 2010, he gave the prestigious Vodafone lecture on mobile health at the Royal Academy of Engineering and the Centenary Lecture on Biomedical Engineering at the Indian Institute of Science in Bangalore. He received the 2015 Martin Black Prize from the Institute of Physics for the best paper in Physiological Measurement [3]
He was appointed a Commander of the Order of the British Empire (CBE) in the 2012 New Year Honours for services to engineering and a 'Chevalier dans l'Ordre national du Mérite' by the French state in 2021.
Tarassenko is married to Dr Anne Tarassenko. He has 3 children and 3 step-children. He is a Lay Canon of Christ Church Cathedral, Oxford. [29]
Health informatics is the field of science and engineering that aims at developing methods and technologies for the acquisition, processing, and study of patient data, which can come from different sources and modalities, such as electronic health records, diagnostic test results, medical scans. The health domain provides an extremely wide variety of problems that can be tackled using computational techniques.
The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
Cambridge University Hospitals NHS Foundation Trust is a British public sector healthcare provider located in Cambridge, England. It was established on 4 November 1992 as Addenbrooke's National Health Service Trust, and authorised as an NHS foundation trust under its current name on 1 July 2004.
Ara Warkes Darzi, Baron Darzi of Denham, is an Armenian-British surgeon, academic, and politician.
John Radcliffe Hospital is a large tertiary teaching hospital in Oxford, England. It forms part of Oxford University Hospitals NHS Foundation Trust and is named after John Radcliffe, an 18th-century physician and Oxford University graduate, who endowed the Radcliffe Infirmary, the main hospital for Oxford from 1770 until 2007.
South London and Maudsley NHS Foundation Trust, also known as SLaM, is an NHS foundation trust based in London, England, which specialises in mental health. It comprises four psychiatric hospitals, the Ladywell Unit based at University Hospital Lewisham, and over 100 community sites and 300 clinical teams. SLaM forms part of the institutions that make up King's Health Partners, an academic health science centre.
University College London Hospitals NHS Foundation Trust (UCLH) is an NHS foundation trust based in London, United Kingdom. It comprises University College Hospital, University College Hospital at Westmoreland Street, the UCH Macmillan Cancer Centre, the Royal National ENT and Eastman Dental Hospitals, the Hospital for Tropical Diseases, the National Hospital for Neurology and Neurosurgery, the Royal London Hospital for Integrated Medicine and the Royal National Throat, Nose and Ear Hospital.
Guy Goodwin is a senior research fellow and until recently was the W.A. Handley Professor of Psychiatry at the University of Oxford (2014). A fellow of the Academy of Medical Sciences, Goodwin has served as principal investigator in many clinical trials for the treatment of bipolar disorder. He is also an Emeritus Senior Investigator at the National Institute for Health and Care Research (NIHR) and has been on the advisory boards of numerous research councils. He was President of the European College of Neuropsychopharmacology from 2013 to 2016.
Christofer "Chris" Toumazou, FRS, FREng, FMedSci, FIET, FIEEE, FCGI, FRSM, CEng is a British Cypriot electronic engineer.
The National Institute for Health and Care Research (NIHR) is the British government’s major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.
The UCLH Biomedical Research Centre is a biomedical research centre based in London. It is a partnership between University College London Hospitals NHS Foundation Trust (UCLH), University College London (UCL) the National Institute for Health and Care Research (NIHR) and UCLPartners. It was one of the original five Comprehensive Biomedical Research Centres established by the NIHR in April 2007.
Mark G. Allen is a professor specializing in microfabrication, nanotechnology, and microelectromechanical systems at the University of Pennsylvania, where he is currently Alfred Fitler Moore Professor of Electrical and Systems Engineering Director of the Singh Center for Nanotechnology, and leader of the Microsensor and Microactuator Research Group. Prior to his joining the University of Pennsylvania in 2013, he was with the Georgia Institute of Technology, where he was Regents' Professor of Electrical and Computer Engineering and the J.M. Pettit Professor in Microelectronics. While at Georgia Tech, he also held multiple administrative positions, including Senior Vice Provost for Research and Innovation; Acting Director of the Georgia Electronic Design Center; and Inaugural Executive Director of Georgia Tech's Institute for Electronics and Nanotechnology. He was editor in chief of the Journal of Micromechanics and Microengineering (JMM), and currently serves on the editorial board of JMM as well as the journal Microsystems and Nanoengineering.
Andrew Jonathan Carr is a British surgeon and has been the sixth Nuffield Professor of Orthopaedics and head of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the University of Oxford since 2001.
Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.
Julia Alison Noble is a British engineer. She has been Technikos Professor of Biomedical Engineering at the University of Oxford and a fellow of St Hilda's College since 2011, and Associate Head of the Mathematical, Physical and Life Sciences Division at the university. As of 2017, she is the chief technology officer of Intelligent Ultrasound Limited, an Oxford spin-off in medical imaging that she cofounded. She was director of the Oxford Institute of Biomedical Engineering (IBME) from 2012 to 2016.In 2023 she became the Foreign Secretary of The Royal Society.
Elizabeth Murray was a British general practitioner and professor of e-health and primary care at University College London. In 2003 she established the eHealth Unit at UCL where she was co-director, and she was also Deputy Director of the UCL Institute of Healthcare Engineering.
The Institute of Global Health Innovation is one of Imperial College London’s global challenge Institutes. Established in 2010, its mission is to improve global health and care through evidence-based innovation. The Institute’s work aims to support the identification, development and implementation of healthcare innovation, with the goal of sustainably reducing inequalities in global health.
Gari David Clifford is a British-American physicist, biomedical engineer, academic, and researcher. He is the Chair of Emory's Department of Biomedical Informatics and a Professor of Biomedical Engineering and Biomedical Informatics at Emory University and Georgia Institute of Technology.
Mohamad Sawan is a Canadian-Lebanese electrical engineer, academic and researcher. He is a Chair Professor at Westlake University, China, and an Emeritus Professor of Electrical Engineering at Polytechnique Montréal, Canada.